---
schema_version: "secwatch.filing_event.v1"
accession: "0001894562-25-000056"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:42:47.836735+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Prime Medicine posts updated corporate presentation; no quantitative details from exhibit.

## Summary
- Updated corporate presentation posted to investor website on September 8, 2025.
- Presentation is dated September 2025 and focuses on Prime Editing platform.
- No specific financial figures, pipeline updates, or new data are visible in the limited exhibit text.

## SEC filing metadata
- accession: 0001894562-25-000056
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000189456225000056/0001894562-25-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000189456225000056/prme-20250908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001894562-25-000056
- JSON: https://secwatch.observer/filing/0001894562-25-000056.json
- Plain text: https://secwatch.observer/filing/0001894562-25-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.